Pravastatin Sodium Tablet
Product Images NDC 84386-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 84386-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pravastatin Fig1)

Figure 1 (Pravastatin Fig1)
A survival distribution Kaplan-Meier curve comparing pravastatin and placebo groups over 5 years, depicting the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction. The graph shows higher survival without events in the pravastatin group, with statistical significance (Logrank P = 0.0001). The x-axis represents years since randomization, and the y-axis represents the proportion of subjects without events.*
FDA Label Image

Package Label-principal Display Panel (80 mg (90 Tablets Bottle))

Package Label-principal Display Panel (80 mg (90 Tablets Bottle))
Pravastatin Sodium Tablets, USP 80 mg oral tablets packaging label showing a quantity of 90 tablets. The label includes the NDC number 84386-034-90 and is distributed by Aurobindo Pharma USA, Inc. It features storage instructions, manufacturer information from the Czech Republic, and prescription-only status. The Aurobindo logo appears on the label.*
FDA Label Image

Chemical Structure (Pravastatin Str)

Chemical Structure (Pravastatin Str)
Chemical structure of Pravastatin sodium, showing its molecular formula C23H35NaO7 and molecular weight of 446.52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.